SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-003261
Filing Date
2018-11-07
Accepted
2018-11-07 08:06:47
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cvsi_10q-093018.htm 10-Q 434950
2 CERTIFICATION cvsi_10q-ex3101.htm EX-31.1 9366
3 CERTIFICATION cvsi_10q-ex3201.htm EX-32.1 3381
  Complete submission text file 0001683168-18-003261.txt   3817958

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE cvsi-20180930.xml EX-101.INS 801252
5 XBRL SCHEMA FILE cvsi-20180930.xsd EX-101.SCH 32153
6 XBRL CALCULATION FILE cvsi-20180930_cal.xml EX-101.CAL 55708
7 XBRL DEFINITION FILE cvsi-20180930_def.xml EX-101.DEF 175539
8 XBRL LABEL FILE cvsi-20180930_lab.xml EX-101.LAB 288401
9 XBRL PRESENTATION FILE cvsi-20180930_pre.xml EX-101.PRE 270356
Mailing Address 2688 SOUTH RAINBOW AVENUE, SUITE B LAS VEGAS NV 89146
Business Address 2688 SOUTH RAINBOW AVENUE, SUITE B LAS VEGAS NV 89146 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54677 | Film No.: 181164773
SIC: 2834 Pharmaceutical Preparations